Log in to save to my catalogue

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity o...

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba8891b4a6314699b53fa292268d5610

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells

About this item

Full title

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2021-11, Vol.6 (1), p.399-399, Article 399

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

HACE1, an E3 ubiquitin-protein ligase, is frequently inactivated and has been evidenced as a putative tumor suppressor in different types of cancer. However, its role in glioma remains elusive. Here, we observed increased expression of HACE1 in gliomas related to control subjects, and found a strong correlation of high HACE1 expression with poor pr...

Alternative Titles

Full title

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ba8891b4a6314699b53fa292268d5610

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba8891b4a6314699b53fa292268d5610

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-021-00793-z

How to access this item